AbCellera Biologics Inc vs Wheaton Precious Metals Corp — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while Wheaton Precious Metals Corp trades at $136.69 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 20.4× AbCellera Biologics Inc's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | WPM | |
|---|---|---|
Market Cap | $2.99B | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $165.72 |
52-Week Low | $2.78 | $91.02 |
Enterprise Value | $2.58B | $62.82B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →